ALMI Invest, together with Första Entreprenörsfonden, has invested SEK 2 million (€218,000) in Sprint Bioscience, a drug development services company specialising in lead generation.
The company carries out commissioned research for the pharmaceutical industry, and is also working to develop its own lead compounds.
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
